Dose-dependent risk of malformations with antiepileptic drugs: An analysis of data from the eurap epilepsy and pregnancy registry

Therapeutic Drug Monitoring

Volumn 37, Issue 5, 2015, Pages 557-558

  Kaplan, Yusuf C ^a,b   Nulman, Irena ^a   Koren, Gideon ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; VALPROIC ACID; ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; CONGENITAL MALFORMATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG SAFETY; EPILEPSY; FAMILY HISTORY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAINTENANCE DRUG DOSE; MATERNAL OBESITY; MONOTHERAPY; NOTE; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY; ABNORMALITIES, DRUG-INDUCED; FEMALE; REGISTER; RISK;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; HUMANS; PREGNANCY; REGISTRIES; RISK;

EID: 84941885819     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000193     Document Type: Note

References (5)

1. Viinikainen K, Heinonen S, Eriksson K, et al. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia. 2006;47:186-192.
2. Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology. 2007;68:326-337.
3. Tomson T, Battino D, Bonizzoni E, et al; EURAP Study Group. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011;10:609-617.
4. Gallus S, Lugo A, Murisic B, et al. Overweight and obesity in 16 European countries. Eur J Nutr. 2014:1-11.
5. Perucca E, Dulac O, Shorvon S, et al. Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs. 2001;15:609-621.